Guardant Health

Company Description

Guardant Health, Inc. is a precision oncology company providing insights into disease drivers through advanced blood and tissue tests, real-world data, and AI analytics to improve cancer outcomes across all stages of care. Its main businesses involve screening for early cancer, monitoring for recurrence, and helping doctors select advanced cancer treatments, including Guardant360 LDT, Guardant360 CDx for NSCLC and breast cancer, Guardant360 Tissue, Guardant Reveal, and Guardant360 Response. The description does not specify different regions of operation. In the last fiscal year, the company had a market cap of $5995 million, profits of $449 million, revenue of $739 million, and 1999 employees.

Analysis

ANALYSIS: With an Obermatt 360° View of 40 (better than 40% compared with alternatives), overall professional sentiment and financial characteristics for the stock Guardant Health are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Guardant Health. The consolidated Value Rank has an attractive rank of 60, which means that the share price of Guardant Health is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 60% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 97, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 29. Professional investors are more confident in 71% other stocks. Worryingly, the company has risky financing, with a Safety rank of 4. This means 96% of comparable companies have a safer financing structure than Guardant Health. ...read more

Country

USA

Industry Health Care Services

Size Small

Website guardanthealth.com

Index

NASDAQ

Add to Watchlist

See Similar Stocks

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.